MRI: The new reference standard in quantifying hepatic steatosis?

Gut

Volumn 61, Issue 1, 2012, Pages 117-127

  Raptis, Dimitri Aristotle ^a   Fischer, Michael Alexander ^a   Graf, Rolf ^a   Nanz, Daniel ^a   Weber, Achim ^a   Moritz, Wolfgang ^a   Tian, Yinghua ^a   Oberkofler, Christian Eugen ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ACCURACY; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CORRELATION ANALYSIS; DISEASE MODEL; FAT CONTENT; FATTY LIVER; FEMALE; HUMAN; INTERMETHOD COMPARISON; ISCHEMIA; LIPID ANALYSIS; LIVER; LIVER FAILURE; LIVER INJURY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGIST; PHANTOM; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RELIABILITY; REPERFUSION; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL;

ADULT; AGED; ANIMALS; CATTLE; FATTY LIVER; FEMALE; HEPATECTOMY; HUMANS; LIPIDS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REFERENCE STANDARDS; REPERFUSION INJURY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 83555178493     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300155     Document Type: Article

References (37)

1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99-112.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
3. Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545-59. (Pubitemid 46588419)
4. Vetelainen R, van Vliet A, Gouma DJ, et al. Steatosis as a risk factor in liver surgery. Ann Surg 2007;245:20-30. (Pubitemid 46035431)
5. Clavien PA, Oberkofler CE, Raptis DA, et al. What is critical for liver surgery and partial liver transplantation: size or quality? Hepatology 2010;52:715-29.
6. Todo S, Demetris AJ, Makowka L, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47:903-5. (Pubitemid 19139140)
7. Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-51. (Pubitemid 27008548)
8. El-Badry AM, Breitenstein S, Jochum W, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009;250:691-7.
9. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500. (Pubitemid 32164902)
10. Kim SH, Lee JM, Han JK, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging-correlation with histopathologic findings. Radiology 2006;240:116-29. (Pubitemid 43902601)
11. Yoshimitsu K, Kuroda Y, Nakamuta M, et al. Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging 2008;28:678-84.
12. Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009;7:135-40.
13. Lee SS, Park SH, Kim HJ, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010;52:579-85.
14. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 2005;237:1048-55. (Pubitemid 41636400)
15. Van Handel E. Rapid determination of total lipids in mosquitoes. J Am Mosq Control Assoc 1985;1:302-4.
16. El-Badry AM, Moritz W, Contaldo C, et al. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology 2007;45:855-63. (Pubitemid 46631553)
17. Fischer MA, Nanz D, Reiner CS, et al. Diagnostic performance and accuracy of 3-D spoiled gradient-dual-echo MRI with water- and fat-signal separation in liver-fat quantification: comparison to liver biopsy. Invest Radiol 2010;45:465-70.
18. Clavien PA, Barkun J, de Oliveira ML, et al. The ClavieneDindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-96.
19. Rinella ME, McCarthy R, Thakrar K, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 2003;9:851-6. (Pubitemid 36974953)
20. Pilleul F, Chave G, Dumortier J, et al. Fatty infiltration of the liver. Detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol 2005;29:1143-7. (Pubitemid 43046359)
21. Schuchmann S, Weigel C, Albrecht L, et al. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging. Eur J Radiol 2007;62:416-22. (Pubitemid 46783361)
22. Fiorini RN, Kirtz J, Periyasamy B, et al. Development of an unbiased method for the estimation of liver steatosis. Clin Transplant 2004;18:700-6. (Pubitemid 39496984)
23. Boyles TH, Johnson S, Garrahan N, et al. A validated method for quantifying macrovesicular hepatic steatosis in chronic hepatitis C. Anal Quant Cytol Histol 2007;29:244-50. (Pubitemid 47311333)
24. Marsman H, Matsushita T, Dierkhising R, et al. Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 2004;35:430-5. (Pubitemid 38507079)
25. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-95. (Pubitemid 39657013)
26. Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51:433-45.
27. Birnbaum BA, Hindman N, Lee J, et al. Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 2007;242:109-19. (Pubitemid 44956015)
28. El-Badry AM, Graf R, Clavien PA. Omega 3-Omega 6: What is right for the liver? J Hepatol 2007;47:718-25. (Pubitemid 47503438)
29. Perez-Daga JA, Santoyo J, Suarez MA, et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transplant Proc 2006;38:2468-70. (Pubitemid 44767862)
30. Nocito A, El-Badry AM, Clavien PA. When is steatosis too much for transplantation? J Hepatol 2006;45:494-9. (Pubitemid 44307398)
31. Yoong KF, Gunson BK, Neil DA, et al. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 1999;31:550-1. (Pubitemid 29127569)
32. Noujaim HM, de Ville de Goyet J, Montero EF, et al. Expanding postmortem donor pool using steatotic liver grafts: a new look. Transplantation 2009;87:919-25.
33. Urena MA, Ruiz-Delgado FC, Gonzalez EM, et al. Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 1998;30:3288-91. (Pubitemid 28538813)
34. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997;64:248-51. (Pubitemid 27332667)
35. Mann DV, Lam WW, Hjelm NM, et al. Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. Hepatology 2001;34:557-65. (Pubitemid 32786647)
36. Corbin IR, Buist R, Volotovskyy V, et al. Regenerative activity and liver function following partial hepatectomy in the rat using (31)P-MR spectroscopy. Hepatology 2002;36:345-53. (Pubitemid 34810353)
37. de Graaf W, Bennink RJ, Vetelainen R, et al. Nuclear imaging techniques for the assessment of hepatic function in liver surgery and transplantation. J Nucl Med 2010;51:742-52.